<DOC>
	<DOC>NCT01839253</DOC>
	<brief_summary>For those who receive hypotensive anesthesia in orthognathic surgeries, the investigators premedicate with anti-hypertensive agent so that it decreases the occurence of tachycardia and the rebound hypertension due to hypotensive anesthesia, enabling us to compare hemodynamic stability and reduction of anesthetic agents during the operation.</brief_summary>
	<brief_title>The Effect of Antihypertensive Agents Concerning With Hemodynamics and Reduction of Anaesthetics in Orthognathic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Anesthetics</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<mesh_term>Atenolol</mesh_term>
	<mesh_term>Enalapril</mesh_term>
	<mesh_term>Angiotensin-Converting Enzyme Inhibitors</mesh_term>
	<criteria>1. ASA class III 2. obtaining written informed consent from the parents 3. aged 1829 years who were undergoing orthognathic surgery. 1. Hypertension patients with antihypertensive agents 2. chronic renal failure or End stage renal disease patients. 3. renal artery stenosis history. 4. Patients who are with medication due to systemic disease. 5. symptomatic asthma 6. Drug hyperactivity 7. neurological or psychiatric illnesses 8. mental retardation 9. patients who can`t read the consent form due to illiterate or foreigner</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>29 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>antihypertensive agents</keyword>
	<keyword>hemodynamic</keyword>
	<keyword>anesthetics reduction</keyword>
	<keyword>orthognathic surgery</keyword>
</DOC>